Hereditary angioedema patients would prefer newer-generation oral prophylaxis-Reference-Cited by-同舟云学术

Hereditary angioedema patients would prefer newer-generation oral prophylaxis

Published:2021-01-06 Issue:1 Volume:10 Page:51-56
ISSN:2155-6660
Container-title:Journal of Drug Assessment
language:en
Short-container-title:Journal of Drug Assessment

Author:

Geba Daniela¹,Mohd Sani Johan¹,Gascon Michaela¹,Hahn Rebecca¹,Aggarwal Kavita²,Rosselli Jinky²

Affiliation:

1. KJT Group, Inc, Honeoye Falls, NY, USA

2. BioCryst Pharmaceuticals, Inc, Durham, NC, USA

Funder

BioCryst

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/21556660.2020.1863699

Reference32 articles.

1. U.S. National Libray of Medicine. [cited 2020 Feb 5]. Available from: https://ghr.nlm.nih.gov/condition/hereditary-angioedema#statistics.

2. Descriptive epidemiology of hereditary angioedema emergency department visits in the United States, 2006‐2007

3. The burden of hospitalizations and emergency department visits with hereditary angioedema and angioedema in the United States, 2007

4. The voice of the patient: hereditary angioedema – report of the U.S. Food and Drug Administration patient-focused drug development initiative public meeting September 2017. Center for Biologics Evaluation and Research (CBER) and U.S. Food and Drug Administration (FDA); 2018.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Androgen transition and management of hereditary angioedema long-term prophylaxis in real life: a single-center case series;Orphanet Journal of Rare Diseases;2024-07-09

2. Hereditary angioedema prevalence and satisfaction with prophylaxis in South Australia;World Allergy Organization Journal;2024-07

3. Transitioning Patients From Second- to First-Line Prophylaxis in Hereditary Angioedema;European Medical Journal;2024-03-14

4. Berotralstat for long-term prophylaxis of hereditary angioedema in Japan: Parts 2 and 3 of the randomized APeX-J Phase III trial;World Allergy Organization Journal;2024-03

5. Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks;Allergy and Asthma Proceedings;2024-01-22